Biotech | September 10, 2025
Evonik and Ethris partner to expand offerings for nucleic acid delivery
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
This project shall be implemented through incorporation of a new joint venture company in Zambia
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Subscribe To Our Newsletter & Stay Updated
